Health ❯ Biotechnology
Protein Engineering Gene Delivery Gene Therapy Monoclonal Antibodies Cancer Research Mast Cell Diseases
The lawsuit alleges undisclosed weaknesses in third‑party manufacturing controls that put briquilimab trial readouts at risk of being confounded.
